galangin
| SMILES | Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccccc1 |
| InChIKey | VCCRNZQBSJXYJD-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 5 |
| Hydrogen bond donors | 3 |
| Rotatable bonds | 1 |
| Molecular weight (Da) | 270.1 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Database connections
| Ligand site mutations | A2A |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| A1 | AA1R | Rat | Adenosine | A | pKi | 6.06 | 6.06 | 6.06 | ChEMBL |
| A3 | AA3R | Human | Adenosine | A | pKi | 5.5 | 5.5 | 5.5 | ChEMBL |
| A2A | AA2AR | Human | Adenosine | A | pKi | 4.48 | 4.67 | 4.78 | ChEMBL |
| A2A | AA2AR | Human | Adenosine | A | pKi | 6.0 | 6.0 | 6.0 | Guide to Pharmacology |
| A3 | AA3R | Human | Adenosine | A | pKi | 5.5 | 5.5 | 5.5 | Guide to Pharmacology |
| A1 | AA1R | Rat | Adenosine | A | pKi | 6.1 | 6.1 | 6.1 | Guide to Pharmacology |
| A2A | AA2AR | Rat | Adenosine | A | pKi | 6.01 | 6.01 | 6.01 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |